1044813-00-4

Basic information

• Product Name: 5-O-[(tert-Butyl)dimethylsilyl]-2,3-O-(1-methylethylidene)-L-lyxonic acid gamma-lactone
• Synonyms: 5-O-[(tert-Butyl)dimethylsilyl]-2,3-O-(1-methylethylidene)-L-lyxonic acid gamma-lactone;5-O-[(dimethylethyl)dimethylsilyl]-2,3-O-Isopropyllidine-L-lyxoniacidr-lactone
• CAS NO: 1044813-00-4
• Molecular Formula: C14H26O5Si
• Molecular Weight: 302.43874
• Mol File: 1044813-00-4.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 371.0±42.0 °C(Predicted)
• Appearance: /
• Density: 1.031
• CAS DataBase Reference: 5-O-[(tert-Butyl)dimethylsilyl]-2,3-O-(1-methylethylidene)-L-lyxonic acid gamma-lactone(CAS DataBase Reference)
• NIST Chemistry Reference: 5-O-[(tert-Butyl)dimethylsilyl]-2,3-O-(1-methylethylidene)-L-lyxonic acid gamma-lactone(1044813-00-4)
• EPA Substance Registry System: 5-O-[(tert-Butyl)dimethylsilyl]-2,3-O-(1-methylethylidene)-L-lyxonic acid gamma-lactone(1044813-00-4)

Safety Data

• Hazardous Substances Data: 1044813-00-4(Hazardous Substances Data)

Usage

General Description

5-O-[(tert-Butyl)dimethylsilyl]-2,3-O-(1-methylethylidene)-L-lyxonic acid gamma-lactone is a chemical compound that is a derivative of the naturally occurring sugar, L-lyxonic acid. It is commonly used in the synthesis of nucleotide analogues and other biologically active compounds. 5-O-[(tert-Butyl)dimethylsilyl]-2,3-O-(1-methylethylidene)-L-lyxonic acid gamma-lactone has a gamma-lactone functional group and contains a tert-butyl and dimethylsilyl substituents, as well as an isopropylidene group. These chemical features make it useful in protecting and manipulating hydroxyl groups in organic synthesis. Additionally, the presence of the lyxose sugar moiety makes this compound potentially useful in carbohydrate chemistry and as a building block for pharmaceuticals and natural product synthesis.

Upstream product

• 18162-48-6 tert-butyldimethylsilyl chloride 
• 152006-17-2 2,3-O-isopropylidene-L-lyxono-1,4-lactone 
• 30725-00-9 2,3-O-isopropylidene-D-ribonic-γ-lactone 
• 5336-08-3 D-Ribono-1,4-lactone 
• 532-20-7 D-Ribose 
• 89747-54-6 (3R,4R,5R)-4,5-dihydro-3,4-(O,O)-isopropylidene-5-mesyloxymethyl-2-(3H)-furanone 

Downstream Products

• 153172-30-6 1-amino-1,4-anhydro-N-benzyl-5-O-tertbutyldimethylsilyl-1-deoxy-2,3-O-isopropylidene-D-ribitol 
• 153172-31-7 (3aR,4R,6aS)-4-({[(tert-butyl)(dimethyl)silyl]oxy}methyl)tetrahydro-2,2-dimethyl-3aH-[1,3]dioxolo[4,5-c]pyrrole 
• 153172-33-9 (3aR,4R,6aS)-4-(((tert-butyldimethylsilyl)oxy)methyl)-2,2-dimethyl-4,6a-dihydro-3aH-[1,3]dioxolo[4,5-c]pyrrole 
• 364046-18-4 1S-5-O-tert-butyldimethylsilyl-1,4-dideoxy-1-C-[(4-methyoxypyrrolo[3,2-d]pyrimidin-9-N-(benzyloxomethyl)-7-yl)]-1,4-imino-2,3-O-isopropylidine-D-ribitol 
• 190315-43-6 (2R,3S,4R)-2-(hydroxymethyl)tetrahydrothiophene-3,4-diol 
• 1610426-19-1 (3aS,4S,6R,6aR)-tert-butyl 4-(2-amino-6-oxo-1,6-dihydropyrimidin-5-yl)-6-((benzyloxy)methyl)-2,2-dimethyldihydro-3aH-[1,3]dioxolo[4,5-c]pyrrole-5(4H)-carboxylate 
• 1610426-18-0 (3aR,4R,6S,6aS)-tert-butyl 4-((benzyloxy)methyl)-6-((Z)-3-(tert-butoxy)-1-methoxy-3-oxoprop-1-en-2-yl)-2,2-dimethyldihydro-3aH-[1,3]dioxolo[4,5-c]pyrrole-5(4H)-carboxylate 
• 1610426-17-9 (3aR,4R,6S,6aS)-tert-butyl 4-((benzyloxy)methyl)-6-((Z)-3-(tert-butoxy)-1-hydroxy-3-oxoprop-1-en-2-yl)-2,2-dimethyldihydro-3aH-[1,3]dioxolo[4,5-c]pyrrole-5(4H)-carboxylate 
• 577978-31-5 (2S,3S,4R,5R)-tert-butyl 2-(5-((benzyloxy)methyl)-4-methoxy-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-3-hydroxy-4-((4-methoxybenzyl)oxy)-5-((trityloxy)methyl)pyrrolidine-1-carboxylate 
• 402477-45-6 (2S,3S,4R,5R)-tert-butyl 2-(5-((benzyloxy)methyl)-4-methoxy-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-4-hydroxy-3-((4-methoxybenzyl)oxy)-5-((trityloxy)methyl)pyrrolidine-1-carboxylate 
• 1163713-16-3 (6aR,8S,9R,9aR)-tert-butyl 8-(5-(benzyloxymethyl)-4-methoxy-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-9-hydroxy-2,2,4,4-tetraisopropyltetrahydro[1,3,5,2,4]trioxadisilocino[7,6-d]pyrrole-7(8H)-carboxylate 
• 917595-31-4 (6aR,8S,9S,9aR)-tert-butyl 8-(5-(benzyloxymethyl)-4-methoxy-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-9-hydroxy-2,2,4,4-tetraisopropyltetrahydro-[1,3,5,2,4]trioxadisilocino[7,6-b]pyrrole-7(8H)-carboxylate 
• 402477-37-6 (2S,3S,4R,5R)-tert-butyl 2-(5-(benzyloxymethyl)-4-methoxy-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidine-1-carboxylate 
• 364046-19-5 1S-N-tert-butoxycarbonyl-5-O-tert-butyldimethylsilyl-1,4-dideoxy-1-C-[(4-methyoxypyrrolo[3,2-d]pyrimidin-9-N-(benzyloxomethyl)-7-yl)]-1,4-imino-2,3-O-isopropylidine-D-ribitol 

Relevant articles and documents

Stereoselective synthesis of 4′-selenonucleosides using the Pummerer glycosylation reaction

The syntheses of four selenonucleosides, namely 4′-β-selenoadenosine, -cytidine, -thymidine, and -uridine are described. Commercially available d-ribonolactone was converted to the key intermediate 1,4-anhydro-4-seleno-d-ribitol in seven steps in overall excellent yield. Oxidation of the seleno-d-ribitol with MCPBA gave a single diastereomeric selenoxide in excellent yield, which upon Pummerer reaction in the presence of silylated purine or pyrimidine bases gave stereoselectively the corresponding 4′-β-selenonucleosides. The stereochemistry at the anomeric center was determined by means of 1D-NOE experiments.

RIBONUCLEIC ACIDs WITH 4'-THIO-MODIFIED NUCLEOTIDES AND RELATED METHODS

Disclosed are messenger RNA molecules and related compositions incorporating a 4'-thio modification in the furanose ring of at least one nucleotide residue, and methods of using these mRNAs to produce an encoded therapeutic protein invivo and to treat or prevent diseases or disorders. In certain embodiments, the 4'-thio modified mRNA provides for enhanced stability and/or reduced immunogenicity in in vivo therapies.

COMPOSITIONS AND METHODS FOR INHIBITING VIRAL POLYMERASE

Provided are compounds of Formula (I) as described herein. Compounds of Formula (I) are useful in methods of inhibiting viral RNA polymerase activity and viral replication. Also provided are pharmaceutical compositions comprising compounds of Formula (I), as well as methods of treating viral infections using compounds of Formula (I).